

[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI

[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
Salveen Richter Initiated (APLS) at Strong Buy and Held Target at $74 on, Nov 9th, 2023
Salveen Richter of Goldman Sachs, Initiated "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy and Held Target at $74 on, Nov 9th, 2023.
Salveen has made no other calls on APLS in the last 4 months.
There are 13 other peers that have a rating on APLS. Out of the 13 peers that are also analyzing APLS, 3 agree with Salveen's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Graig Suvannavejh of "Mizuho" Initiated at Hold and Held Target at $42 on, Thursday, November 2nd, 2023
- Brian Cheng of "B of A Securities" Maintained at Hold with Increased Target to $46 on, Thursday, October 12th, 2023
- Laura Chico of "Wedbush" Reiterated at Hold and Held Target at $29 on, Wednesday, August 23rd, 2023
These are the ratings of the 10 analyists that currently disagree with Salveen
- Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Increased Target to $93 on, Thursday, November 2nd, 2023
- Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $63 on, Wednesday, November 1st, 2023
- Anupam Rama of "JP Morgan" Upgraded from Hold to Buy and Increased Target to $81 on, Friday, October 6th, 2023
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $70 on, Friday, October 6th, 2023
- Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $82 on, Tuesday, September 26th, 2023
- Derek Archila of "Wells Fargo" Upgraded from Hold to Buy and Increased Target to $64 on, Friday, September 15th, 2023
- Annabel Samimy of "Stifel" Maintained at Strong Buy with Increased Target to $65 on, Tuesday, August 29th, 2023
- Justin Kim of "Oppenheimer" Reiterated at Buy on, Wednesday, August 23rd, 2023
- Eliana Merle of "UBS" Maintained at Strong Buy with Increased Target to $64 on, Wednesday, August 23rd, 2023
- Colleen Kusy of "Baird" Maintained at Buy with Decreased Target to $70 on, Tuesday, August 1st, 2023
Contributing Sources